NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Derralynn Hughes
University College London - London / United Kingdom
Others
AD Scientific Index ID: 1364410
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Derralynn Hughes's MOST POPULAR ARTICLES
1-)
Treatment of Fabry’s disease with the pharmacologic chaperone migalastatDP Germain, DA Hughes, K Nicholls, DG Bichet, R Giugliani, WR Wilcox, ...New England Journal of Medicine 375 (6), 545-555, 20165102016
2-)
Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mappingDM Sado, SK White, SK Piechnik, SM Banypersad, T Treibel, G Captur, ...Circulation: Cardiovascular Imaging 6 (3), 392-398, 20135022013
3-)
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT studyDA Hughes, K Nicholls, SP Shankar, G Sunder-Plassmann, D Koeller, ...Journal of medical genetics 54 (4), 288-296, 20174222017
4-)
Effects of enzyme replacement therapy on the cardiomyopathy of Anderson–Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfaDA Hughes, PM Elliott, J Shah, J Zuckerman, G Coghlan, J Brookes, ...Heart 94 (2), 153-158, 20084162008
5-)
Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptorI Fraser, D Hughes, S GordonNature 364 (6435), 343-346, 19934111993
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept